Find by identifier
CAS number index
39,377 CAS Registry Numbers in numeric order. A number with several grades opens a comparison page, a single match opens the product.
| CAS number | Substance | Listings |
|---|---|---|
| 868272-85-9 | 3,3'-Diaminobenzidine tetrahydrochloride, 98%+ | 1 |
| 868350-97-4 | Bromazepam EP Impurity C | 1 |
| 868539-96-2 | Methyl | 1 |
| 868540-15-2 | (AS)-a-[[(1,1-Dimethylethoxy)carbonyl]amino]benzenebutanoyl-L-leucyl-phenylmethyl Ester L-Phenylalanine | 1 |
| 868540-16-3 | (S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid | 1 |
| 868540-17-4 | Carfilzomib WS | 1 |
| 868540-22-1 | tert-Butyl ((S)-1-(((S)-4-methyl-1-(((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopentan-2-yl)amino)-1-oxo-4-phenylbutan-2-yl)carbamate | 1 |
| 868680-84-6 | Metazosulfuron | 1 |
| 868754-41-0 | Pioglitazone EP Impurity D | 1 |
| 868754-42-1 | Pioglitazone EP Impurity E | 1 |
| 868993-14-0 | Mycophenolate Di-Mofetil | 1 |
| 869112-14-1 | 1-(2-Chloroethyl)-4-piperidinecarboxylic Acid Ethyl Ester | 1 |
| 869112-31-2 | 4-(Hydroxydiphenylmethyl)-1-(2-hydroxyethyl)quinuclidin-1-ium Bromide | 1 |
| 869113-09-7 | Umeclidinium Bromide | 1 |
| 869113-10-0 | 1-Benzyl-4-(hydroxydiphenylmethyl)quinuclidin-1-ium Bromide | 1 |
| 869113-45-1 | 1-(2-(Benzoyloxy)ethyl)-4-(hydroxydiphenylmethyl)quinuclidin-1-ium Bromide | 1 |
| 869368-48-9 | Ritonavir EP Impurity T | 1 |
| 869377-50-4 | Carbamazepine Impurity 11 | 1 |
| 869477-96-3 | Olodaterol Hydrochloride | 1 |
| 869478-12-6 | (R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one | 1 |
| 869501-51-9 | Ethyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate | 1 |
| 869627-85-0 | 3(R,S)-Hydroxy Desogestrel | 1 |
| 869631-11-8 | Candesartan Cilexetil EP impurity B | 1 |
| 869791-42-4 | Pemetrexed EP Impurity A (Freebase) | 1 |
| 869858-84-4 | 1-Ethyl-3-methylimidazolium dibutyl phosphate, ≥97.0% (HPLC) | 1 |
| 869884-00-4 | (S)-1,2,3,4-Tetrahydro-1-phenylisoquinoline D-(-)-tartrate | 1 |
| 870076-72-5 | Salbutamol EP Impurity A | 1 |
| 870196-80-8 | 4-Cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanoic acid, 97% (HPLC) | 1 |
| 870196-83-1 | 2-Cyano-2-propyl dodecyl trithiocarbonate, 97% | 1 |
| 870243-67-7 | 2-(2-tert-Butoxyethoxy)-1H-isoindole-1,3(2H)-dione | 1 |
| 870281-74-6 | Desfluoro Idelalisib | 1 |
| 870281-82-6 | Idelalisib | 1 |
| 870614-82-7 | 4-Dehydroxy-4-dimethylhydroxysilyl Entecavir | 1 |
| 870703-68-7 | 3,6-Dibromo-2-fluorobenzaldehyde | 1 |
| 870765-38-1 | Aripiprazole Hydroxybutyl Impurity | 1 |
| 870964-67-3 | Evocalcet | 1 |
| 870987-63-6 | (Ir[dF(CF3)ppy]2(dtbpy))PF6 | 1 |
| 870991-70-1 | (1R,2R)-1,2-Bis(2-hydroxyphenyl)ethylenediamine | 1 |
| 870995-64-5 | 5-Methoxystrictamine | 1 |
| 871038-72-1 | Raltegravir Potassium | 1 |
| 871100-19-5 | Milnacipran EP Impurity M | 1 |
| 871132-03-5 | Dalbavancin B2 | 1 |
| 871239-18-8 | 2-Amino-5-Cyano-3-Methylbenzoic Acid | 1 |
| 871550-15-1 | Fluconazole EP Impurity B | 1 |
| 871555-75-8 | Phenyl (4-chloro-3-(trifluoromethyl)phenyl)carbamate | 1 |
| 871577-78-5 | 2-[1-(Aminomethyl)-3-methylbutyl]propanedioic acid | 1 |
| 871700-17-3 | Trametinib | 1 |
| 871700-22-0 | Trametinib Impurity 11 | 1 |
| 871700-24-2 | Trametinib Hydroxy Impurity | 1 |
| 871700-25-3 | Trametinib Anilide Impurity | 1 |
| 871700-30-0 | (E)-N'-(1-Cyclopropyl-3-(2-fluoro-4-iodophenyl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-N,N-dimethylformimidamide | 1 |
| 871700-65-1 | Desiodo Trametinib | 1 |
| 871701-87-0 | Trametinib Desacetyl Impurity | 1 |
| 871825-57-9 | N-Methyl-1-(1-methyl-1H-pyrazol-3-yl)methanamine | 1 |
| 871884-77-4 | N-Nitroso N-Desethyl Alverine | 1 |
| 872041-02-6 | Olopatadine Amide Impurity | 1 |
| 872100-54-4 | Oleracein A | 1 |
| 872100-55-5 | Oleracein B | 1 |
| 872108-14-0 | 2-[(Morpholine-4-sulfonyl)methyl]benzonitrile | 1 |
| 872351-69-4 | (2E,6E,10Z)-1-Bromo-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraene | 1 |
| 872414-52-3 | 2-(Bromomethyl)benzamide | 1 |
| 872469-60-8 | BPAMD [Bis(phosphonate) monoamide analogues of DOTA | 1 |
| 872728-81-9 | Dabigatran Etexilate Mesylate | 1 |
| 872818-45-6 | 5,5-bis(bromomethyl)-1,3,2-dioxathiane 2-oxide | 1 |
| 872825-79-1 | 1-Nitroso-4-(pyridin-2-yl)piperazine | 1 |
| 872826-80-7 | 2-(4-nitrosopiperazin-1-yl)pyrimidine | 1 |
| 872980-38-6 | Empagliflozin Methoxy Impurity | 1 |
| 872992-20-6 | Linezolid R-Isomer | 1 |
| 873012-43-2 | 2-(Bromomethyl)-2-(2-chloro-4-(4-chlorophenoxy)phenyl)-4-methyl-1,3-dioxolane, 97% | 1 |
| 873051-52-6 | Ivacaftor Ortho Isomer | 1 |
| 873054-39-8 | De-Alkylated Ivacaftor | 1 |
| 873054-44-5 | Ivacaftor | 1 |
| 873055-35-7 | 5-Amino-2-tert-butylphenol | 1 |
| 873055-55-1 | 2,4-Di-tert-butyl-5-nitrophenyl methyl carbonate | 1 |
| 873055-57-3 | 2,4-Di-tert-butyl-5-nitrophenol | 1 |
| 873055-58-4 | Phenol, 5-amino-2,4-bis(1,1-dimethylethyl) | 1 |
| 873056-63-4 | (2`,5`-Difluoro[1,1`-biphenyl]-2-amine) | 1 |
| 873077-70-4 | Sunitinib Impurity-E | 1 |
| 873310-28-2 | N-Methyl-3-phenyl-3-(m-tolyloxy)propan-1-amine Hydrochloride | 1 |
| 873310-31-7 | N-Methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine Hydrochloride | 1 |
| 873310-33-9 | Atomoxetine EP Impurity A HCl | 1 |
| 873407-01-3 | Doxylamine EP Impurity A | 1 |
| 873417-25-5 | 4-Amino-3-chloro-5-methylphenol | 1 |
| 873436-91-0 | PU-H71 Trifluoroacetic Acid | 1 |
| 873857-62-6 | Fidaxomicin | 1 |
| 873862-33-0 | Methyl 3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylate | 1 |
| 873874-39-6 | Des-[Oct-y-Glu-AEEA-AEEA]-Semaglutide | 1 |
| 873895-41-1 | Olanzapine Amino Impurity | 1 |
| 873950-17-5 | Atorvastatin Cyclic Isopropyl Impurity | 1 |
| 873950-18-6 | Atorvastatin Cyclic Fluorophenyl Impurity | 1 |
| 873950-19-7 | Atorvastatin Epoxy Tetrahydrofuran Analog | 1 |
| 873976-38-6 | Ethyl 8-Ethoxyoctanoate | 1 |
| 874195-61-6 | Triafamone | 1 |
| 874290-59-2 | 4-(Benzyloxycarbonylamino)-2-fluorophenylboronicacid | 1 |
| 874340-08-6 | Linezolid Desacetamide Descarbonyl Phthalimide (R)-Isomer | 1 |
| 874459-75-3 | 4-(2-Acetamidoethyl)phenylboronic acid | 1 |
| 874519-13-8 | 3-p-Anisoyl Acacetin | 1 |
| 874583-40-1 | Naratriptan Impurity 15 | 1 |
| 874638-80-9 | ((2R,3R,4R)-3-(Benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl Benzoate | 1 |
| 874747-30-5 | Pentoxifylline EP Impurity J | 1 |
| 874760-69-7 | Lenalidomide Impurity-13 | 1 |
| 874760-71-1 | (S)-5-Amino-2-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic acid | 1 |
| 874760-72-2 | (S)-5-Amino-4-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoic Acid | 1 |
| 874817-93-3 | 2-Chloro-3-iodobenzoic acid | 1 |
| 874908-11-9 | rac-2-Despiperidyl-2-amino Repaglinide | 1 |
| 874946-00-6 | (3R)-3-(7-Amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione | 1 |
| 874967-67-6 | Sedaxane | 1 |
| 875148-45-1 | Regadenoson Hydrate | 1 |
| 875167-01-4 | 3-Chloro-5-trifluoromethylphenylsulfonyl chloride | 1 |
| 875252-65-6 | Prilocaine EP Impurity D | 1 |
| 875535-35-6 | Diacerein EP Impurity D | 1 |
| 875535-36-7 | Diacerein EP Impurity E | 1 |
| 875573-60-7 | Fulvestrant Impurity 22 | 1 |
| 875573-63-0 | (7alpha,17Beta)-17-(Acetyloxy)-7-(9-bromononyl)estr-4-en-3-one | 1 |
| 875712-90-6 | Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate | 1 |
| 875756-97-1 | bisBenzimide H 33342 trihydrochloride, ≥98% | 1 |
| 875775-74-9 | Flometoquin | 1 |
| 875781-15-0 | 5-Bromo-2-fluoro-3-formylpyridine, 97% | 1 |
| 875781-41-2 | 5-Bromo-3-[(trimethylsilyl)ethynyl]pyrazin-2-amine | 1 |
| 875781-43-4 | 2-Bromo-5H-Pyrrolo[2,3-b]Pyrazine | 1 |
| 875901-66-9 | Tert-Butyl O-(tert-butyl)-L-allothreoninate | 1 |
| 875915-78-9 | Isofetamid | 1 |
| 876014-27-6 | Ethyl (1S,5R,6R)-5-hydroxy-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate | 1 |
| 876316-33-5 | 2-(Morpholinomethyl)phenylboronic acid, pinacol ester | 1 |
| 876322-73-5 | 4-Amino-2-trifluoromethylbenzaldehyde | 1 |
| 876403-98-4 | Topiramate EP Impurity B | 1 |
| 876473-73-3 | Amylmetacresol EP Impurity A | 1 |
| 876497-65-3 | 3-(Nitrosoamino)benzaldehyde | 1 |
| 876509-01-2 | 2,3,4,4a,5,9b-Hexahydro-1H-pyrido[4,3-b]indole | 1 |
| 876514-31-7 | Nebivolol USP Related Compound C | 1 |
| 876666-07-8 | Rel-N-Benzyl Nebivolol | 1 |
| 876903-48-9 | 5-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]-2-hydroxybenzoic Acid | 1 |
| 877177-42-9 | Tert-Butyl 4-nitrosopiperazine-1-carboxylate | 1 |
| 877265-30-0 | Terbinafine Impurity C (Hydrochloride) | 1 |
| 877265-33-3 | Terbinafine EP Impurity D (Hydrochloride) | 1 |
| 877397-71-2 | Crizotinib Amine Impurity | 1 |
| 877399-00-3 | (R)-5-Bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine | 1 |
| 877399-51-4 | tert-Butyl (R)-4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate | 1 |
| 877399-52-5 | Crizotinib | 1 |
| 877399-74-1 | tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate | 1 |
| 877402-45-4 | Sitagliptin Pyrazinone Impurity | 1 |
| 877612-13-0 | 1-(3-Isobutylphenyl)ethanone | 1 |
| 877777-10-1 | Propoxyphenyl Sildenafil | 1 |
| 877963-94-5 | LOC14, ≥98% | 1 |
| 878002-84-7 | N-Pivaly-Cefditoren Pivoxil | 1 |
| 878132-19-5 | 1-Ethyl-3-methylimidazolium L-(+)-lactate, ≥95% (HPLC | 1 |
| 878453-71-5 | 4-{[1-({3-[4-(Trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}methyl)-3-piperidinyl]methyl}morpholine | 1 |
| 878480-70-7 | Glimepiride EP Impurity I | 1 |
| 878630-84-3 | (S)-tert-Butyl 4-aminoazepane-1-carboxylate | 1 |
| 878650-31-8 | Methyl 2,6-dichloro-5-methoxypyrimidine-4-carboxylate, 98% | 1 |
| 878672-00-5 | Lesinurad | 1 |
| 878782-79-7 | 4-Amino-a-(3-amino-3-oxopropyl)1,3-dihydro-1-oxo-2H-Isoindole-2-aceticacidmethylester | 1 |
| 878784-75-9 | Alverine EP Impurity E HCl | 1 |
| 878791-35-6 | Prilocaine EP impurity D HCl | 1 |
| 879005-96-6 | Pefloxacin EP Impurity E | 1 |
| 879085-55-9 | Vismodegib | 1 |
| 879088-40-1 | 2-(2-Chloro-5-nitrophenyl)pyridine | 1 |
| 879088-41-2 | 4-Chloro-3-(pyridin-2-yl)benzenamine | 1 |
| 879396-70-0 | Silodosin Glucuronide | 1 |
| 879515-14-7 | 3-(Aminomethyl)oxolan-3-ol | 1 |
| 879551-01-6 | (4S,5R)-Ethyl 5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-methyl-1,3,2-dioxathiolane-4-carboxylate 2,2-dioxide | 1 |
| 879562-26-2 | Olmesartan EP Impurity C | 1 |
| 879643-71-7 | Formamidinium iodide, 99% | 1 |
| 879644-03-8 | N-(4-Chloro-3-methoxyphenyl)-2-cyanoacetamide | 1 |
| 879646-17-0 | N-Formyl Trimetazidine Hydrochloride | 1 |
| 879671-67-7 | Doxylamine Succinate EP Impurity B Hydrochloride | 1 |
| 880084-63-9 | 1-Ethyl-3-methylimidazolium 1,1,2,2-tetrafluoroethanesulfonate, ≥95% (HPLC) | 1 |
| 880088-78-8 | 4-(Cyclopropylcarbonyl)-α,α-dimethylbenzeneacetic Acid Methyl Ester | 1 |
| 880106-10-5 | Spironolactone EP impurity G | 1 |
| 880149-29-1 | Bismuth subcitrate potassium | 1 |
| 880152-61-4 | Ramelteon lsobutyryl impurity | 1 |
| 880152-62-5 | (S)-N-(2-(7,8-Dihydro-6H-indeno[5,4-b]furan-8-yl)ethyl)propionamide | 1 |
| 880152-63-6 | N,N'-(((8S,8'S)-1,1',6,6',7,7',8,8'-Octahydro-2H,2'H-[4,6'-biindeno[5,4-b]furan]-8,8'-diyl)bis(ethane-2,1-diyl))dipropionamide | 1 |
| 880468-89-3 | Lacosamide Impurity A | 1 |
| 880769-28-8 | Montelukast Chloroalcohol impurity | 1 |
| 881376-41-6 | Pinoxaden Metabolite SYN505164 | 1 |
| 881376-42-7 | Pinoxaden Metabolite SYN502836 | 1 |
| 881386-01-2 | 3,3-Dichloro-1-(4-nitrophenyl)piperidin-2-one, 97% | 1 |
| 881386-12-5 | Apixaban Related Compound G | 1 |
| 881399-30-0 | Amido Ethyl Meloxicam | 1 |
| 881674-56-2 | 5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde | 1 |
| 881674-58-4 | (5-(2-Fluorophenyl)-1H-pyrrol-3-yl)methanol | 1 |
| 881676-32-0 | 5-Bromo-1H-pyrrole-3-carbaldehyde | 1 |
| 881677-11-8 | Vonoprazan Sulfonyl Aldehyde Impurity | 1 |
| 881681-00-1 | Vonoprazan | 1 |
| 881681-01-2 | Vonoprazan Fumarate | 1 |
| 881685-58-1 | Isopyrazam | 1 |
| 881732-90-7 | N-Methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine | 1 |
| 881733-36-4 | 1-(5-(4-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine | 1 |
| 881896-95-3 | 6α-(Methoxymethyl)androsta-1,4-dien-3,17-dione | 1 |
| 881995-46-6 | Desmethyl Atomoxetine Hydrochloride | 1 |
| 881995-69-3 | (R)-Sitagliptin Methyl-Ester Impurity | 1 |
| 881995-70-6 | Sitagliptin Amino Butenoate Impurity | 1 |
| 881995-73-9 | (R)-Sitagliptin N-Boc-Methyl-Ester Impurity | 1 |
| 882073-43-0 | Millad NX 8000 | 1 |
| 882167-77-3 | 4-Chloro-N-methylpyridine-2-carboxamide Hydrochloride | 1 |
| 882434-87-9 | Ramelteon ene amine amide | 1 |
| 882521-63-3 | 2-Amino-7-bromo-[1,2,4]triazolo[1,5-a]pyridine | 1 |
| 882691-14-7 | Fingolimod Monoester Impurity A | 1 |
| 882697-00-9 | Emrusolmin | 1 |
| 882880-12-8 | 1,4-Bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane | 1 |
| 883150-73-0 | Strontium aluminate, europium and dysprosium doped | 1 |
| 883225-99-8 | Dicloxacillin Degradation Impurity (DCMICAA) | 1 |
| 883553-87-5 | Pemetrexed L-Glutamyl-L-Glutamic Acid | 1 |
| 883793-48-4 | Canagliflozin Impurity 16 | 1 |
| 884305-06-0 | 6-Chloro-5-(2-chloro-1-hydroxyethyl)-1,3-dihydro-2H-indol-2-one | 1 |
| 884311-05-1 | Formyl L-Penicillamine | 1 |
| 884320-54-1 | 3-Iodothyronamine-[ethylamino-1,1,2,2-d4] hydrochloride | 1 |
| 884330-09-0 | Telmisartan-desmethyl dibenzimidazole Impurity | 1 |
| 884330-10-3 | 1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-ol | 1 |
| 884330-12-5 | Telmisartan EP Impurity E | 1 |
| 884330-14-7 | Telmisartan Dimer Impurity | 1 |
| 884330-16-9 | Telmisartan Impurity 25 | 1 |
| 884330-17-0 | 3-Amino-4-(butyramido)-5-methyl-N-(2-(methylamino)phenyl)benzamide | 1 |
| 884495-14-1 | 5-Bromo-2-methoxy-4-methyl-3-nitropyridine | 1 |
| 884497-46-5 | Methyl 3-amino-5-fluorobenzoate | 1 |
| 884740-09-4 | Donepezil Hydrochloride Monohydrate | 1 |
| 885045-90-9 | Telmisartan EP Impurity J | 1 |
| 885100-76-5 | 6-(4-Fluorophenyl)-1,4-dihydro-4-(1-methylethyl)-2-(methylthio)-5-pyrimidinecarboxylic acid methyl ester | 1 |
| 885101-12-2 | N-Methyl Fluoxetine Hydrochloride | 1 |
| 885112-31-2 | 4-Desdimethylamine 4-Oxo Omadacycline | 1 |
| 885126-35-2 | Axitinib Tetrahydro-2H-pyran | 1 |
| 885126-40-9 | Axitinib Z-isomer | 1 |
| 885274-75-9 | 2-(4-Boc-piperazinyl)-2-(3-thienyl)acetic acid | 1 |
| 885280-56-8 | 2-Amino-n-cyclopentyl-acetamide | 1 |
| 885315-96-8 | Kongensin A | 1 |
| 885340-11-4 | 1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carbonitrile | 1 |
| 885340-13-6 | Silodosin Nitrile Impurity | 1 |
| 885959-36-4 | 4-(Pyrrolidin-3-yl)piperazine-1-carboxylic Acid tert-Butyl Ester | 1 |
| 886061-26-3 | (S)-3-Amino-3-(4-chlorophenyl)-1-propanol | 1 |
| 886230-77-9 | (E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole | 1 |
| 886373-11-1 | (3-Amino-5-bromopyridin-2-yl)acetic acid | 1 |
| 886439-34-5 | 1-Butyl-1-methylpiperidinium tetrafluoroborate, 99% | 1 |
| 886498-55-1 | 2,6-Difluoro-3-methoxybenzyl bromide | 1 |
| 886538-46-1 | Cytidine Ester | 1 |
| 886538-48-3 | Uridine 5'-(2-Methylpropanoate) | 1 |
| 886588-63-2 | N-Phthalimide-Linagliptin | 1 |
| 886844-32-2 | 4-OH-phenyl-florasulam | 1 |
| 886979-78-8 | (R)-Bortezomib Hydroperoxy Impurity | 1 |
| 886979-81-3 | Bortezomib USP Related Compoud M | 1 |
| 886996-37-8 | (S)-2-Amino-5-((S)-2-amino-3-carboxypropanamido)pentanoic acid | 1 |
| 886999-34-4 | N2-Trityl Candesartan Cilexetil | 1 |
| 886999-35-5 | N-Triphenylmethyl Irbesartan | 1 |
| 887001-08-3 | Rizatriptan EP Impurity A | 1 |
| 887130-68-9 | Beclometasone Dipropionate EP Impurity E | 1 |
| 887130-69-0 | Beclomethasone Dipropionate EP Impurity F | 1 |
| 887144-97-0 | Togni reagent, ≥97% | 1 |
| 887196-24-9 | Atorvastatin EP Impurity F | 1 |
| 887196-25-0 | (3S,5R)-Atorvastatin Calcium | 1 |
| 887256-40-8 | Mesalazine EP Impurity P | 1 |
Or browse by name